The Three Volcanoes Park LLC will build a world-class tourism cluster in the area of Vilyuchinsky, Mutnovsky and Gorely volcanoes, with access to Vilyuchinsky Bay. More Topics "Three Volcanoes" Park
Polyoxidonium (azoximer bromide) - the Russian original drug produced by Petrovax- was approved by the Ministry of Health of the Russian Federation for conducting an international clinical trial for the treatment of COVID-19.More Topics Petrovax Pharm
The Ministry for the Development of the Russian Far East and Arctic, Rostourism, the Government of the Kamchatka Region, and the «Three Volcanoes Park» signed a strategic cooperation agreement.
Sergey Tyrtsev, First Deputy Minister for Development of the Russian Far East and Arctic; Zarina Doguzova, head of Rostourism; Vladimir Ilyukhin, Governor of the Kamchatka region; and Sergey Bachin, Chairman of the Board of the «Three Volcanoes Park», signed the strategic cooperation agreement at the Eastern Economic Forum in order to launch an investment project to create a world-class resort and accessible-to-all recreation infrastructure around the Mutnovsky, Vilyuchinsky and Gorely volcanoes of the Three Volcanoes Park.More Topics "Three Volcanoes" Park
The first place in the nomination «Medicine of choice for the treatment and prevention of SARS and influenza among children» was granted to «Polyoxidonium», produced by NGO Petrovax Pharm.More Topics Petrovax Pharm
In July 2018, Petrovax Pharm received Marketing Authorization No. LP-004951 for Grippol® Quadrivalent, a 4-valent inactivated subunit adjuvanted vaccine designed for prevention of influenza. It is the most advanced flu vaccine in the world that employs an antigen sparing technology and has a high preventive activity and safety.More Topics Petrovax Pharm